Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAP18 pseudogene 2 (SAP18P2) is classified as a **pseudogene** in the human genome, sharing sequence similarity with the functional SAP18 gene but lacking protein-coding capacity[6][7]. Pseudogenes generally do not produce functional proteins due to mutations or regulatory disruptions[2][6]. While some pseudogenes can regulate gene expression or interfere with regulatory RNAs, there is currently no evidence that SAP18P2 is such a functional pseudogene, nor is there evidence of clinical biomarker or drug targeting relevance. Pseudogenes are not considered therapeutic targets because they by definition lack protein products for pharmacologic interaction, although they may occasionally participate in regulatory RNA crosstalk in rare contexts[2][6][7]. **Key clarifying points:** - The **canonical protein-coding gene is "Sin3A associated protein 18" (SAP18)**, which is involved in histone modification and transcriptional repression[1][3][4][5]. However, SAP18P2 is not a protein-coding gene, but a non-functional (as currently annotated) pseudogene copy. - **SAP18P2 is not a therapeutic target** and has **no known ligands, drugs, or associated mechanisms**. - There is **no evidence for biological or disease roles**, biomarkers, or clinical impact specific to SAP18P2 at this time. If your goal is to target a protein or functional gene, you should refer to the **canonical SAP18 protein** and not SAP18 pseudogene 2. If you need information about SAP18 instead, let me know.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAP18 pseudogene 2 (SAP18P2).